Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASCO 2021 | Initial report from NCCAPS on hospitalized cancer patients with COVID-19

Alok Khorana, MD, Cleveland Clinic, Cleveland, OH, outlines the findings of a report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS). Preliminary analysis of NCCAPS data suggests that inpatient hospitalization is common among patients with cancer during COVID-19; these patients also experience higher mortality. Hematologic malignancies and lung cancer are the most common underlying diagnoses in patients requiring hospitalization. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Disclosures

Alok Khorana, MD has received funding/roles from Janssen, Bayer, BMS, Pfizer, Anthos.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.